Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol target-controlled infusion model establishment and accuracy study
ChiCTR2300071603Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- May 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol, sponsored by Renji Hospital. Primary endpoint: Plasma concentration of ciprofol in arterial blood. Planned start May 2023; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2300071603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071603.